These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor. Hornell TM; Beresford GW; Bushey A; Boss JM; Mellins ED J Immunol; 2003 Sep; 171(5):2374-83. PubMed ID: 12928384 [TBL] [Abstract][Full Text] [Related]
26. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM. Peterson M; Sant AJ J Immunol; 1998 Sep; 161(6):2961-7. PubMed ID: 9743359 [TBL] [Abstract][Full Text] [Related]
27. Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation. Fallas JL; Tobin HM; Lou O; Guo D; Sant'Angelo DB; Denzin LK J Immunol; 2004 Aug; 173(3):1549-60. PubMed ID: 15265882 [TBL] [Abstract][Full Text] [Related]
28. Another twist to MHC-peptide recognition. Wilson IA Science; 1996 May; 272(5264):973-4. PubMed ID: 8638141 [No Abstract] [Full Text] [Related]
29. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Roche PA; Marks MS; Cresswell P Nature; 1991 Dec; 354(6352):392-4. PubMed ID: 1956401 [TBL] [Abstract][Full Text] [Related]
30. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules. Stebbins CC; Peterson ME; Suh WM; Sant AJ J Immunol; 1996 Dec; 157(11):4892-8. PubMed ID: 8943393 [TBL] [Abstract][Full Text] [Related]
31. Self-release of CLIP in peptide loading of HLA-DR molecules. Kropshofer H; Vogt AB; Stern LJ; Hämmerling GJ Science; 1995 Nov; 270(5240):1357-9. PubMed ID: 7481823 [TBL] [Abstract][Full Text] [Related]
32. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain. Neumann J; König A; Koch N Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964 [TBL] [Abstract][Full Text] [Related]
33. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion. Neumann J; Eis-Hübinger AM; Koch N J Immunol; 2003 Sep; 171(6):3075-83. PubMed ID: 12960333 [TBL] [Abstract][Full Text] [Related]
34. CD4 binding to major histocompatibility complex class II antigens induces LFA-1-dependent and -independent homotypic adhesion of B lymphocytes. Kansas GS; Cambier JC; Tedder TF Eur J Immunol; 1992 Jan; 22(1):147-52. PubMed ID: 1730248 [TBL] [Abstract][Full Text] [Related]
35. High-level intrinsic disorder explains the universality of CLIP binding to diverse MHC class II variants. Uversky VN; Tu YN; Nwogu O; Butler SN; Ramsamooj M; Blanck G Cell Mol Immunol; 2018 Jan; 15(1):76-78. PubMed ID: 28757614 [No Abstract] [Full Text] [Related]
36. Multiple signals regulate the intracellular trafficking of HLA-DM in B-lymphoblastoid cells. Copier J; Potter P; Sacks SH; Kelly AP Immunology; 1998 Apr; 93(4):505-10. PubMed ID: 9659222 [TBL] [Abstract][Full Text] [Related]
37. CLIP-region mediated interaction of Invariant chain with MHC class I molecules. Powis SJ FEBS Lett; 2006 May; 580(13):3112-6. PubMed ID: 16678175 [TBL] [Abstract][Full Text] [Related]
38. The kinetic basis of peptide exchange catalysis by HLA-DM. Zarutskie JA; Busch R; Zavala-Ruiz Z; Rushe M; Mellins ED; Stern LJ Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12450-5. PubMed ID: 11606721 [TBL] [Abstract][Full Text] [Related]